BE842688A - Derives d'anilides de l'acide cyanoacetique, leur procede de preparation et leur application - Google Patents
Derives d'anilides de l'acide cyanoacetique, leur procede de preparation et leur applicationInfo
- Publication number
- BE842688A BE842688A BE167706A BE167706A BE842688A BE 842688 A BE842688 A BE 842688A BE 167706 A BE167706 A BE 167706A BE 167706 A BE167706 A BE 167706A BE 842688 A BE842688 A BE 842688A
- Authority
- BE
- Belgium
- Prior art keywords
- preparation
- application
- cyanoacetic acid
- anilide derivatives
- anilide
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D317/00—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms
- C07D317/08—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3
- C07D317/44—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3 ortho- or peri-condensed with carbocyclic rings or ring systems
- C07D317/46—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3 ortho- or peri-condensed with carbocyclic rings or ring systems condensed with one six-membered ring
- C07D317/48—Methylenedioxybenzenes or hydrogenated methylenedioxybenzenes, unsubstituted on the hetero ring
- C07D317/62—Methylenedioxybenzenes or hydrogenated methylenedioxybenzenes, unsubstituted on the hetero ring with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to atoms of the carbocyclic ring
- C07D317/66—Nitrogen atoms not forming part of a nitro radical
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C255/00—Carboxylic acid nitriles
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D261/00—Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings
- C07D261/02—Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings not condensed with other rings
- C07D261/06—Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings not condensed with other rings having two or more double bonds between ring members or between ring members and non-ring members
- C07D261/10—Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings not condensed with other rings having two or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D261/18—Carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pain & Pain Management (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Engineering & Computer Science (AREA)
- Neurosurgery (AREA)
- Neurology (AREA)
- Biomedical Technology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Rheumatology (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Heterocyclic Compounds That Contain Two Or More Ring Oxygen Atoms (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
DE2524929A DE2524929C3 (de) | 1975-06-05 | 1975-06-05 | 2-Hydroxyäthylidencyanessigsäureanilide, Verfahren zu ihrer Herstellung und diese Verbindungen enthaltende Mittel |
Publications (1)
Publication Number | Publication Date |
---|---|
BE842688A true BE842688A (fr) | 1976-12-08 |
Family
ID=5948272
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
BE167706A BE842688A (fr) | 1975-06-05 | 1976-06-08 | Derives d'anilides de l'acide cyanoacetique, leur procede de preparation et leur application |
Country Status (15)
Country | Link |
---|---|
US (1) | US4061767A (fr) |
JP (1) | JPS6032620B2 (fr) |
AT (1) | AT343641B (fr) |
BE (1) | BE842688A (fr) |
CA (1) | CA1082202A (fr) |
CH (1) | CH627444A5 (fr) |
DE (1) | DE2524929C3 (fr) |
DK (1) | DK157078C (fr) |
FR (1) | FR2313031A1 (fr) |
GB (1) | GB1555555A (fr) |
IE (1) | IE43004B1 (fr) |
IT (1) | IT1063593B (fr) |
LU (1) | LU75075A1 (fr) |
MX (1) | MX3170E (fr) |
NL (2) | NL186239C (fr) |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP0021207A1 (fr) * | 1979-06-11 | 1981-01-07 | Ciba-Geigy Ag | Alphacarbamoyle-pyrrolpropionitriles, procédé pour leur préparation et compositions pharmaceutiques les contenant |
Families Citing this family (57)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4181677A (en) * | 1978-12-13 | 1980-01-01 | American Cyanamid Company | 2-Benzoyl-3-alkoxy-2-alkenonitriles |
JPS55500866A (fr) * | 1978-11-03 | 1980-10-30 | ||
US4173650A (en) * | 1978-11-03 | 1979-11-06 | American Cyanamid Company | Cis-2-benzoyl-3-hydroxy-2-alkenonitriles as anti-inflammatory agents |
US4259256A (en) * | 1978-12-13 | 1981-03-31 | American Cyanamid Company | 2-Benzoyl-3-dimethylamino-2-alkenonitriles |
US4256759A (en) * | 1979-06-11 | 1981-03-17 | Ciba-Geigy Corporation | Alphacarbamoyl-pyrrolpropionitriles |
US4277420A (en) * | 1979-09-24 | 1981-07-07 | Monsanto Company | Ephedrine and pseudoephedrine precursors |
US4254048A (en) * | 1979-12-17 | 1981-03-03 | American Cyanamid Company | Substituted phenyl alkylidene acetoacetonitriles |
US4254047A (en) * | 1979-12-17 | 1981-03-03 | American Cyanamid Company | Substituted phenyl-2-cyano-2-thioalkenoic acid esters |
US4254049A (en) * | 1979-12-17 | 1981-03-03 | American Cyanamid Company | Substituted phenyl-2-cyano-2-alkenoic acid esters |
US4435407A (en) | 1982-01-07 | 1984-03-06 | Ciba-Geigy Corporation | Certain substituted β-oxo-α-carbamoylpyrrolepropionitriles |
US4644010A (en) * | 1982-09-28 | 1987-02-17 | Ciba-Geigy Corporation | Certain β-oxo-α-carbamoylpyrrolepropionitriles |
DE3247454A1 (de) * | 1982-12-22 | 1984-06-28 | Laboratorios Bago S.A., Buenos Aires | Substituierte 3-phenyl-5-methyl-isoxazol-4-carboxy-anilide, verfahren zu ihrer herstellung und diese verbindungen enthaltende arzneimittel |
DE3534440A1 (de) * | 1985-09-27 | 1987-04-02 | Hoechst Ag | Arzneimittel gegen chronische graft-versus-host-krankheiten sowie gegen autoimmunerkrankungen, insbesondere systemischen lupus erythematodes |
US5268382A (en) * | 1985-09-27 | 1993-12-07 | Hoechst Aktiengesellschaft | Medicaments to combat autoimmune diseases, in particular systemic lupus erythematosus |
GB8619432D0 (en) * | 1986-08-08 | 1986-09-17 | Lilly Industries Ltd | Pharmaceutical compounds |
GB8619433D0 (en) * | 1986-08-08 | 1986-09-17 | Lilly Industries Ltd | Pharmaceutical compounds |
US4888357A (en) * | 1988-01-26 | 1989-12-19 | Bristol-Myers Company | Antiarthritic β-cycloalkyl-β-oxopropionitriles |
US4975462A (en) * | 1988-07-29 | 1990-12-04 | Bristol-Myers Company | Antiarthritic α-arylcarbamoyl cyanoacetic acid derivatives |
DD297328A5 (de) | 1989-08-18 | 1992-01-09 | �������@���������k���Kk�� | 5-methyl-isoxalol-4-carbonsaeureanilide und 2 hydroxyethyliden-cyanoessigsaeureanilide zur behandlung von augenerkrankungen |
US5583150A (en) * | 1989-08-18 | 1996-12-10 | Alcon Laboratories, Inc. | 5-methyl-isoxazole-4-carboxylic acid anilides and 2-hydroxyethylidene-cyano acetic anilides for the treatment of ocular diseases |
US5034410A (en) * | 1989-10-11 | 1991-07-23 | Syntex (U.S.A.) Inc. | Anthelmintically active benzenepropanamide derivatives |
AU649421B2 (en) * | 1990-05-18 | 1994-05-26 | Sanofi-Aventis Deutschland Gmbh | Isoxazole-4-carboxamides and hydroxyalkylidene-cyanoacetamides, drugs containing these compounds and use of such drugs |
ZA913762B (en) | 1990-05-18 | 1992-01-29 | Hoechst Ag | Isoxazole-4-carboxamides and hydroxyalkylidenecyanoacetamides,pharmaceuticals containing these compounds and their use |
ATE141950T1 (de) * | 1990-12-24 | 1996-09-15 | Hoechst Ag | Verfahren zur acylierung von alkoholen mit einem immobilisierten pseudomonas-lipase |
US6133301A (en) * | 1991-08-22 | 2000-10-17 | Aventis Pharma Deutschland Gmbh | Pharmaceuticals for the treatment of rejection reactions in organ transplantations |
DE4127737A1 (de) | 1991-08-22 | 1993-02-25 | Hoechst Ag | Arzneimittel zur behandlung von abstossungsreaktionen bei organverpflanzungen |
IL102790A (en) * | 1991-09-17 | 1996-01-31 | Roussel Uclaf | History of 3-cycloalkyl-prop-2-anamide |
NZ244814A (en) * | 1991-10-23 | 1994-06-27 | Hoechst Ag | N-phenyl-2-cyano-3-hydroxycrotonamide derivatives and pharmaceutical compositions |
GB9200275D0 (en) * | 1992-01-08 | 1992-02-26 | Roussel Lab Ltd | Chemical compounds |
GB9209330D0 (en) * | 1992-04-30 | 1992-06-17 | Roussel Lab Ltd | Chemical compounds |
GB9300083D0 (en) | 1993-01-05 | 1993-03-03 | Roussel Lab Ltd | Chemical compounds |
TW314467B (fr) * | 1993-03-31 | 1997-09-01 | Hoechst Ag | |
RU2139092C1 (ru) * | 1993-06-03 | 1999-10-10 | Терапьютик Антибодиз Инк. | Фрагменты антител в терапии |
GB9313365D0 (en) * | 1993-06-29 | 1993-08-11 | Roussel Lab Ltd | Chemical compounds |
GB9322781D0 (en) * | 1993-11-04 | 1993-12-22 | Roussel Lab Ltd | Aromatic amides |
LT3589B (en) | 1993-11-30 | 1995-12-27 | Hoechst Ag | Using of known combination for treatment of rejection reaction by transplantation of organs |
US5700823A (en) * | 1994-01-07 | 1997-12-23 | Sugen, Inc. | Treatment of platelet derived growth factor related disorders such as cancers |
US5519042A (en) * | 1994-01-13 | 1996-05-21 | Hoechst Aktiengesellschaft | Method of treating hyperproliferative vascular disease |
US6331555B1 (en) | 1995-06-01 | 2001-12-18 | University Of California | Treatment of platelet derived growth factor related disorders such as cancers |
DE19539638A1 (de) * | 1995-10-25 | 1997-04-30 | Hoechst Ag | Die Verwendung von Isoxazol- und Crotonsäureamidderivaten zur Behandlung von Krebserkrankungen |
DE19547648A1 (de) * | 1995-12-20 | 1997-06-26 | Hoechst Ag | Zubereitung, enthaltend High Density Lipoproteine und Crotonsäureamidderivate |
US5981536A (en) * | 1996-07-31 | 1999-11-09 | Hoechst Aktiengesellschaft | Use of xanthine derivatives for the modulation of apoptosis |
US5856330A (en) * | 1996-07-31 | 1999-01-05 | Hoechst Aktiengesellschaft | Use of xanthine derivatives for the inhibition of dephosphorylation of cofilin |
US6011051A (en) * | 1996-07-31 | 2000-01-04 | Hoechst Aktiengesellschaft | Use of isoxazole and crotonamide derivatives for the modulation of apoptosis |
US6316479B1 (en) | 1997-05-19 | 2001-11-13 | Sugen, Inc. | Isoxazole-4-carboxamide compounds active against protein tryosine kinase related disorders |
DE59800287D1 (de) * | 1997-08-08 | 2000-11-09 | Aventis Pharma Gmbh | Kristallform von 5-Methylisoxazol-4-carbonsäure-(4-trifluormethyl)-anilid |
US6355678B1 (en) * | 1998-06-29 | 2002-03-12 | Parker Hughes Institute | Inhibitors of the EGF-receptor tyrosine kinase and methods for their use |
US20050255071A1 (en) * | 1998-12-10 | 2005-11-17 | Aventis Pharma Deutschland Gmbh | Preparation having improved therapeutic breadth comprising nucleotide synthesis inhibitors |
GB0123571D0 (en) * | 2001-04-05 | 2001-11-21 | Aventis Pharm Prod Inc | Use of (Z)-2-cyano-3-hydroxy-but-2-enoic acid-(4'-trifluoromethylphenyl)-amide for treating multiple sclerosis |
DE10132308A1 (de) * | 2001-07-06 | 2003-01-30 | Aventis Behring Gmbh | Kombinationspräparat zur Therapie von immunologischen Erkrankungen |
MXPA04000224A (es) | 2001-07-10 | 2005-07-25 | 4Sc Ag | Novedosos compuestos como agentes antiinflamatorios, inmunomoduladores y antiproliferativos. |
US20050158371A1 (en) * | 2002-02-12 | 2005-07-21 | Sumitomo Pharmaceuticals Co., Ltd. | Novel external agent |
PL209303B1 (pl) | 2002-12-23 | 2011-08-31 | 4Sc Ag | Związek aromatyczny, kompozycja farmaceutyczna zawierająca związek aromatyczny i zastosowanie związku aromatycznego jako środka przeciwzapalnego, immunomodulującego i antyproliferacyjnego |
UA108760C2 (uk) | 2010-07-01 | 2015-06-10 | Кальцієві солі сполуки як протизапальні, імуномодулюючі та антипроліферативні засоби | |
CN105916522A (zh) | 2013-11-22 | 2016-08-31 | 建新公司 | 用于治疗神经变性疾病的新方法 |
MA51998B1 (fr) | 2018-03-16 | 2024-05-31 | Immunic Ag | Nouveaux polymorphes de sel de calcium en tant qu'agents anti-inflammatoires, immunomodulateurs et anti-prolifératifs |
US11376232B2 (en) | 2020-04-21 | 2022-07-05 | Immunic Ag | Vidofludimus for use in the treatment or prevention of viral diseases |
Family Cites Families (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US2288863A (en) * | 1940-02-27 | 1942-07-07 | Hoffmann La Roche | Process for the manufacture of substituted amides of 3,5-dimethylisoxazole-4-carboxylic acid |
BE506549A (fr) * | 1950-10-19 |
-
0
- NL NLAANVRAGE7605845,A patent/NL186239B/xx unknown
-
1975
- 1975-06-05 DE DE2524929A patent/DE2524929C3/de not_active Expired
-
1976
- 1976-05-31 NL NLAANVRAGE7605845,A patent/NL186239C/xx not_active IP Right Cessation
- 1976-06-02 CH CH696376A patent/CH627444A5/de not_active IP Right Cessation
- 1976-06-03 LU LU75075A patent/LU75075A1/xx unknown
- 1976-06-03 US US05/692,318 patent/US4061767A/en not_active Expired - Lifetime
- 1976-06-03 IT IT23922/76A patent/IT1063593B/it active
- 1976-06-04 IE IE1203/76A patent/IE43004B1/en unknown
- 1976-06-04 MX MX000269U patent/MX3170E/es unknown
- 1976-06-04 FR FR7617042A patent/FR2313031A1/fr active Granted
- 1976-06-04 DK DK248476A patent/DK157078C/da active
- 1976-06-04 JP JP51065477A patent/JPS6032620B2/ja not_active Expired
- 1976-06-04 AT AT413576A patent/AT343641B/de not_active IP Right Cessation
- 1976-06-04 CA CA254,136A patent/CA1082202A/fr not_active Expired
- 1976-06-07 GB GB23437/76A patent/GB1555555A/en not_active Expired
- 1976-06-08 BE BE167706A patent/BE842688A/fr not_active IP Right Cessation
Cited By (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP0021207A1 (fr) * | 1979-06-11 | 1981-01-07 | Ciba-Geigy Ag | Alphacarbamoyle-pyrrolpropionitriles, procédé pour leur préparation et compositions pharmaceutiques les contenant |
EP0143142A3 (fr) * | 1979-06-11 | 1985-07-17 | Ciba-Geigy Ag | Alphacarbamoyle-pyrrolpropionitriles, procédés de préparation et compositions pharmaceutiques les contenant ainsi que leurs utilisations thérapeutiques |
Also Published As
Publication number | Publication date |
---|---|
FR2313031B1 (fr) | 1979-10-12 |
CH627444A5 (de) | 1982-01-15 |
DE2524929A1 (de) | 1976-12-16 |
JPS527929A (en) | 1977-01-21 |
NL186239B (nl) | |
JPS6032620B2 (ja) | 1985-07-29 |
IE43004L (en) | 1976-12-05 |
AT343641B (de) | 1978-06-12 |
MX3170E (es) | 1980-06-05 |
DE2524929C3 (de) | 1980-10-09 |
US4061767A (en) | 1977-12-06 |
LU75075A1 (fr) | 1977-03-07 |
DK248476A (da) | 1976-12-06 |
NL186239C (nl) | 1990-10-16 |
CA1082202A (fr) | 1980-07-22 |
FR2313031A1 (fr) | 1976-12-31 |
GB1555555A (en) | 1979-11-14 |
DK157078B (da) | 1989-11-06 |
IE43004B1 (en) | 1980-12-03 |
ATA413576A (de) | 1977-10-15 |
DE2524929B2 (de) | 1980-01-31 |
DK157078C (da) | 1990-04-09 |
IT1063593B (it) | 1985-02-11 |
NL7605845A (en) | 1976-12-07 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
BE842688A (fr) | Derives d'anilides de l'acide cyanoacetique, leur procede de preparation et leur application | |
BE837311A (fr) | Derives d'acide benzoique, leur procede de preparation et leur application | |
FR2318627A1 (fr) | Derives de l'acide phenylacetique et leur procede de preparation | |
BE857541A (fr) | Derives d'acide prostanoique et leur procede de preparation | |
BE864112A (fr) | Derives d'acide benzoique, leur procede de preparation et leur application en therapeutique | |
FR2281340A1 (fr) | Derives de l'acide folique, leur procede de preparation et leur application | |
BE783320A (fr) | Derives de l'acide phenylacetique, leur procede de preparation et leursapplications | |
BE818209A (fr) | Derives de l'acide 7-acylamino-3-cephene-4-carboxylique et leur procede de preparation | |
FR2472561B1 (fr) | Derives de l'acide 4-guanidinomethylcyclohexane carboxylique, leur procede de preparation et leur application en therapeutique | |
BE823692A (fr) | Nouveaux derives d'acide prostanoique et leur procede de preparation | |
FR2334350A2 (fr) | Nouveaux derives d'anilides de l'acide cyanoacetique, leur procede de preparation et leur application | |
BE828546A (fr) | Nouveaux derives d'amino-acides et leur procede de preparation | |
BE831298A (fr) | Nouveaux derives d'acide prostanoique et leur procede de preparation | |
BE819890A (fr) | Nouveaux derives d'acide pyrazolyloxyacetique et leur procede de preparation | |
BE849343R (fr) | Derives d'anilides de l'acide cyanoacetique, leur procede de preparation et leur application | |
FR2353556A1 (fr) | Derives de l'acide clavulanique, leur procede de preparation et leur application en therapeutique | |
BE815742A (fr) | Nouveaux derives d'acide prostanoique et leur procede de preparation | |
FR2299859A1 (fr) | Derives d'acide glycyrrhetinique, leur procede de preparation et leur application | |
BE841165A (fr) | Derives d'acides 8-aza-prostanoiques et leur procede de preparation | |
FR2323690A1 (fr) | Nouveaux derives de n-(1,2,4-triazine-5-one-4-yl)-glycine, leur procede de preparation et leur application comme herbicides | |
BE856326A (fr) | Nouveaux derives d'acide prostanoique et leur procede de preparation | |
BE833184A (fr) | Derives d'acide 3-sulfamoylbenzoique a substants basiques et leur procede de preparation | |
BE820005A (fr) | Amides d'acide benzimidazole-1-carboxylique et leur procede de preparation | |
BE834305A (fr) | Arylamides d'acide omega-aminoalkanoique, leur procede de preparation et leur application | |
BE760793A (fr) | Nouveaux derives d'amide d'acide-alpha-aminoxy-carboxylique et leur procede de preparation |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
RE20 | Patent expired |
Owner name: HOECHST A.G. Effective date: 19960608 |